Literature DB >> 6294791

Comparative susceptibility of Yersinia enterocolitica, Eikenella corrodens, and penicillin-resistant and penicillin-susceptible Streptococcus pneumoniae to beta-lactam and alternative antimicrobial agents.

E J Goldstein, C E Cherubin, M L Corrado, M F Sierra.   

Abstract

The antimicrobial susceptibilities were determined for 14 strains of Yersinia enterocolitica, 28 strains of Eikenella corrodens, 10 strains of penicillin-resistant Streptococcus pneumoniae, and 10 strains of penicillin-susceptible S. pneumoniae. Y. enterocolitica was found to be susceptible to the aminoglycosides tested and to chloramphenicol, moxalactam, cefoperazone, and cefotaxime but resistant to ampicillin and variably susceptible to carbenicillin, cefoxitin, and cefazolin. On a weight basis, cefotaxime and moxalactam were the most active agents against E. corrodens. Most strains of E. corrodens were resistant to the aminoglycosides tested: gentamicin, tobramycin, kanamycin, and amikacin. Penicillin-resistant S. pneumoniae was most susceptible to cefotaxime and moxalactam. Cefotaxime was consistently active against all tested strains of Y. enterocolitica, E. corrodens, and penicillin-resistant S. pneumoniae, three unusual but clinically significant pathogens.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6294791     DOI: 10.1093/clinids/4.supplement_2.s406

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  4 in total

1.  Infective endocarditis due to Eikenella corrodens: Case report and review of the literature.

Authors:  W D Patrick; W D Brown; M Ian Bowmer; C P Sinave
Journal:  Can J Infect Dis       Date:  1990

Review 2.  Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  A A Carmine; R N Brogden; R C Heel; J A Romankiewicz; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-10       Impact factor: 9.546

Review 3.  Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-03       Impact factor: 9.546

4.  Eikenella corrodens Sepsis with Cerebrospinal Fluid Pleocytosis in a Very Low Birth Weight Neonate.

Authors:  Christopher Sawyer; Dimitrios Angelis; Robert Bennett
Journal:  Case Rep Pediatr       Date:  2015-11-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.